About Psyence Biomed
Psyence Biomed is a company based in Scarborough (Canada) founded in 2023.. The company has 12 employees as of March 31, 2024. Psyence Biomed has completed 1 acquisition, including Clairvoyant Therapeutics. Psyence Biomed offers products and services including Psilocybin-based Therapeutics and PsyLabs APIs. Psyence Biomed operates in a competitive market with competitors including Alto Neuroscience, Supernus Pharmaceuticals, Newron Pharmaceuticals, Reunion Neuroscience and Cerecor, among others.
- Headquarter Scarborough, Canada
- Employees 12 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Psyence Group Inc
-
Annual Revenue
$00as on Mar 31, 2024
-
Net Profit
$1.01 M101.97as on Mar 31, 2024
-
EBITDA
$-3.66 M-32.97as on Mar 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
12
as on Mar 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Psyence Biomed
Psyence Biomed is a publicly listed company on the NASDAQ with ticker symbol PBM in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Psyence Biomed
Psyence Biomed offers a comprehensive portfolio of products and services, including Psilocybin-based Therapeutics and PsyLabs APIs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Botanical medicines for treating anxiety and depression in palliative care
Active ingredients for research and clinical trial development
Funding Insights of Psyence Biomed
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Psyence Biomed
Psyence Biomed has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Clairvoyant Therapeutics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Psychedelic therapy drugs for addiction treatment are manufactured.
|
2021 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Psyence Biomed
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Psyence Biomed Comparisons
Competitors of Psyence Biomed
Psyence Biomed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Alto Neuroscience, Supernus Pharmaceuticals, Newron Pharmaceuticals, Reunion Neuroscience and Cerecor, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-driven drug discovery platform for neurological diseases based on patients biomarkers
|
|
| domain | founded_year | HQ Location |
Specialty pharmaceutical products for CNS diseases are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Therapies for central nervous system diseases and pain are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for mental health conditions are developed using serotonergic psychedelics.
|
|
| domain | founded_year | HQ Location |
Therapeutics for immunological and neurological disorders are developed.
|
|
| domain | founded_year | HQ Location |
Neurochemical modulators for ADHD treatment are developed by Neurovance.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Psyence Biomed
Frequently Asked Questions about Psyence Biomed
When was Psyence Biomed founded?
Psyence Biomed was founded in 2023.
Where is Psyence Biomed located?
Psyence Biomed is headquartered in Scarborough, Canada. It is registered at Scarborough, Ontario, Canada.
How many employees does Psyence Biomed have?
As of Mar 31, 2024, the latest employee count at Psyence Biomed is 12.
What does Psyence Biomed do?
Psyence Biomed was founded in 2023 and is based in Scarborough, Canada. Focus is placed on the biotechnology sector, where nature-derived psilocybin is evaluated as a treatment for Adjustment Disorder in patients with advanced cancer diagnoses within palliative care settings. Operations involve the development of psychedelic medicines aimed at addressing mental health challenges in medical contexts.
Who are the top competitors of Psyence Biomed?
Psyence Biomed's top competitors include Alto Neuroscience, Supernus Pharmaceuticals and Newron Pharmaceuticals.
What products or services does Psyence Biomed offer?
Psyence Biomed offers Psilocybin-based Therapeutics and PsyLabs APIs.
Is Psyence Biomed publicly traded?
Yes, Psyence Biomed is publicly traded on NASDAQ under the ticker symbol PBM.
How many acquisitions has Psyence Biomed made?
Psyence Biomed has made 1 acquisition, including Clairvoyant Therapeutics.
What is Psyence Biomed's ticker symbol?
The ticker symbol of Psyence Biomed is PBM on NASDAQ.